Laricrocin92-116 protects Larimichthys crocea against Vibrio parahaemolyticus infection through antibacterial activity, antioxidant effects, and enhanced host immune responses
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.117286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Zhenzhen Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen 361102, China. Hauptthemen laut MEDLINE: Vibrio parahaemolyticus, Vibrio Infections, Perciformes, Fish Diseases. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Xiamen University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Vibrio parahaemolyticus is a halophilic Gram-negative bacterium widely distributed in marine and estuarine environments, and is an important pathogen associated with human and animal infections. The increasing prevalence of antibiotic resistance has prompted the development of alternative antimicrobial strategies. Antimicrobial peptides (AMPs), especially those derived from marine organisms, have attracted increasing attention due to their broad-spectrum activity and low tendency to induce resistance. In this study, a novel AMP, Laricrocin92-116, was identified from the large yellow croaker Larimichthys crocea. Laricrocin92-116 showed broad-spectrum antimicrobial activity, rapid bactericidal kinetics, and excellent stability. In addition, Laricrocin92-116 showed negligible cytotoxicity and hemolytic activity, indicating favorable biosafety. In infected fish models, Laricrocin92-116 significantly improved survival rates. In juvenile large yellow croaker, pretreatment with Laricrocin92-116 markedly reduced bacterial burden and alleviated pathological damage in the intestine and spleen. Furthermore, Laricrocin92-116 modulated the expression of immune-related genes and enhanced antioxidant defenses during infection. Mechanistic studies showed that it disrupted bacterial membrane integrity, induced intracellular oxidative imbalance, inhibited biofilm formation and bacterial motility, thereby impairing bacterial virulence. Collectively, these findings demonstrate that Laricrocin92-116 effectively protects L. crocea against V. parahaemolyticus infection and represents a promising alternative antimicrobial agent for the prevention of vibriosis in aquaculture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen 361102, China.
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen 361102, China; State-Province Joint Engineering Research Center of Marine Bioproducts and Technology,…
Förderung
- Xiamen University
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Z., Ge, J., Hao, H., Chen, F., & Wang, K. J. (2026). Laricrocin92-116 protects Larimichthys crocea against Vibrio parahaemolyticus infection through antibacterial activity, antioxidant effects, and enhanced host immune responses. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117286
Vancouver
Zhou Z, Ge J, Hao H, Chen F, Wang KJ. Laricrocin92-116 protects Larimichthys crocea against Vibrio parahaemolyticus infection through antibacterial activity, antioxidant effects, and enhanced host immune responses. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117286
BibTeX
@article{Zhou2026,
author = {Zhou, Zhenzhen and Ge, Jianhui and Hao, Hua and Chen, Fangyi and Wang, Ke-Jian},
title = {Laricrocin92-116 protects Larimichthys crocea against Vibrio parahaemolyticus infection through antibacterial activity, antioxidant effects, and enhanced host immune responses},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.117286}
}
EUVIMED